Determine the necessary mass, volume, or concentration for preparing a solution.
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
Moligand™, 10mM in DMSO Moligand™ for sensitive chromatographic and analytical workflows requiring minimal baseline interference.
Store at -80°C Ships Dry ice packs + Cold packs Check lot-specific COA for exact specifications.
SDS, COA, datasheet, and spec sheet available for download. Lot-specific COA accessible via lot number lookup.
Cited in 26 peer-reviewed publications across chromatography, organic synthesis, and cross-coupling reactions.
Information
Decitabine (NSC 127716) Decitabine (NSC 127716, Deoxycytidine, Dacogen, 5-aza-2-deoxycytidine, 5-AZA-dC, 5-aza-CdR) is a DNA methyltransferase inhibitor, incorporating into DNA and resulting in hypomethylation of DNA and intra-S-phase arrest of DNA repl
In vitro
Decitabine inhibits cell growth in a dose and time-dependent manner with IC50 of approximately 438 nM and 43.8 nM for 72 hours and 96 hours exposure in HL-60 and KG1a leukemic cells, respectively. A recent study shows that Decitabine exhibits high anti-proliferative and pro-apoptotic activity against anaplastic large cell lymphoma (ALCL), and inhibits [3H]–thymidine uptake in KARPAS-299 cells with EC50 of 0.49 μM.
In vivo
In a ALK+ KARPAS-299 murine xenograft model, Decitabine at a dose of 2.5 mg/kg causes increased apoptosis and reduced proliferation of tumor cells, and also results in demethylation of tumor suppressor p16INK4A.
Cell Data
cell lines:A498, FaO and NRP 154 cells
Concentrations:0-500 nM
Incubation Time:96 hours
Powder Purity:≥99%
| Isómeros SMILES | C1[C@@H]([C@H](O[C@H]1N2C=NC(=NC2=O)N)CO)O |
|---|---|
| WGK Alemania | 3 |
| RTECS | XZ3012000 |
| Peso molecular | 228.21 |
| Beilstein | 617982 |
| Reaxy-Rn | 24922554 |
| Reaxys-RN_link_address | https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=24922554&ln= |
Comprehensive hazard, handling, storage, and regulatory compliance document.
Download SDS →Lot-specific quality data. Enter your lot number to retrieve the exact COA.
Look up COA →Full quality attributes and acceptance criteria for this grade.
View spec sheet →| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
| Punto de fusión (°C) | 191 °C(dec.) |
|---|
| 1. Shiquan Sun, Yong He, Jiaqi Xu, Shaolong Leng, Yu Liu, Huanhuan Wan, Leping Yan, Yunsheng Xu. (2024) Enhancing cell pyroptosis with biomimetic nanoparticles for melanoma chemo-immunotherapy. JOURNAL OF CONTROLLED RELEASE, [PMID:38290565] [10.1016/j.jconrel.2024.01.057] |
| 2. Xiaohui Gao, Hui Zeng, Fei Sun, Xiaoyan Zhao, Haibing Wu, Minchao Yan, Yuan Li, Qinyan Fu, Gang Zhang. (2025) Mechanism of action of decitabine in treating acute lymphoblastic leukemia. Frontiers in Medicine, [PMID:40809438] [10.3389/fmed.2025.1614592] |
| 3. Tengfei Ma, Tong Li, Qiuhua Chen, Xiangyou Yue, Xin Mao, Bing Zhang. (2025) Comparative analysis of membrane fouling control by modified microbial flocculant for pre-coagulation in two representative granular sludge-membrane coupling systems. Journal of Environmental Chemical Engineering, [PMID:] [10.1016/j.jece.2025.118547] |
| 4. Huimin Xie, Lin Ma, Xiaoli He, Songsong Zhao, Jin Wang, Ao Zhu, Changming Liu, Olga Piskareva, Chao Deng, Fenghua Meng, Mi Liu. (2025) Elevating MHC I expression on tumor cells by nanovesicles loading tyrosine kinase inhibitors can improve the efficacy of cancer vaccines. Frontiers in Immunology, [PMID:41019037] [10.3389/fimmu.2025.1653533] |
| 5. Jiahao Hu, Yuchan You, Luwen Zhu, Jucong Zhang, Yanling Song, Jingyi Lu, Xinyi Xu, Xiaochuan Wu, Xiajie Huang, Xiaoling Xu, Yongzhong Du. (2023) Sialic Acid-Functionalized Pyroptosis Nanotuner for Epigenetic Regulation and Enhanced Cancer Immunotherapy. Small, [PMID:37880861] [10.1002/smll.202306905] |
| 6. Shuoyi Zhang, Ming Zhong, Hongbo Zhu, Qinghua You, Hao Yuan, Yongping Li. (2023) Hypomethylation of DRD2 promotes breast cancer through the FLNA-ERK pathway. Cancer Genetics, [PMID:37729778] [10.1016/j.cancergen.2023.09.001] |
| 7. Weichu Zhu, Jian Xu, Xianxian Yao, Shuting Mai, Dan Shu, Wuli Yang. (2023) Metal–organic-framework-based pyroptosis nanotuner with long blood circulation for augmented chemotherapy. Biomaterials Science, [PMID:37470092] [10.1039/D3BM00813D] |
| 8. An Yaqian, Yu Zhiqi, Liu Di, Han Lirong, Zhang Xian, Xin Xuelian, Li Cuiping. (2023) HpaII-assisted and linear amplification-enhanced isothermal exponential amplification fluorescent strategy for rapid and sensitive detection of DNA methyltransferase activity. ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 415 (12): (2271-2280). [PMID:36961574] [10.1007/s00216-023-04647-1] |
| 9. Fan Du, Ting Jin, Li Wang. (2023) Mechanism of Action of Decitabine in the Treatment of Acute Myeloid Leukemia by Regulating LINC00599. Analytical Cellular Pathology, [PMID:36874552] [10.1155/2023/2951519] |
| 10. Hailin Yu, Huili Zhang, Xin Wei, Yong Chen, Bo Yu, Yingjun Wang, Hongsheng Liu. (2022) Preparation of a cationic block copolymer composite coagulant TP(AM-DAC-PPFS) and its coagulation performance for treating oilfield sewage. PROCESS SAFETY AND ENVIRONMENTAL PROTECTION, [PMID:] [10.1016/j.psep.2022.12.060] |
| 11. Tong Gao, Xiao Sang, Xinyan Huang, Panpan Gu, Jie Liu, Yongjun Liu, Na Zhang. (2022) Macrophage-camouflaged epigenetic nanoinducers enhance chemoimmunotherapy in triple negative breast cancer. Acta Pharmaceutica Sinica B, [PMID:37799382] [10.1016/j.apsb.2022.11.018] |
| 12. Shi Guang, Feng Juan, Jian Ling-Yan, Fan Xin-Yu. (2022) DNA hypomethylation promotes learning and memory recovery in a rat model of cerebral ischemia/reperfusion injury. Neural Regeneration Research, 18 (4): (863). [PMID:36204855] [10.4103/1673-5374.353494] |
| 13. Duan Houyu, Ding Xiang, Luo Hesheng. (2022) KISS-1, Mediated by Promoter Methylation, Suppresses Esophageal Squamous Cell Carcinoma Metastasis via MMP2/9/MAPK Axis. DIGESTIVE DISEASES AND SCIENCES, 67 (10): (4780-4796). [PMID:34993679] [10.1007/s10620-021-07335-1] |
| 14. Peng Yi, Xiongfeng Xu, Jiawei Yao, Bo Qiu. (2021) Effect of DNA methylation on gene transcription is associated with the distribution of methylation sites across the genome in osteoarthritis. Experimental and Therapeutic Medicine, 22 (1): (1-8). [PMID:34007328] [10.3892/etm.2021.10151] |
| 15. Yafei Wang, Huimin Liu, Jianmin Wu, Yunjian Liao, Daifeng Lu, Feng Dong, Hongxi Li, Zhitao Zhang, Yongyun Lian. (2020) 5-Aza-2-deoxycytidine inhibits osteolysis induced by titanium particles by regulating RANKL/OPG ratio. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, [PMID:32736684] [10.1016/j.bbrc.2020.05.192] |
| 16. Mengmeng Shu, Shijun Long, Yiwan Huang, Dapeng Li, Haiyan Li, Xuefeng Li. (2019) High strength and antibacterial polyelectrolyte complex CS/HS hydrogel films for wound healing. Soft Matter, 15 (38): (7686-7694). [PMID:31498364] [10.1039/C9SM01380F] |
| 17. Li Zhang, Xiaofen Xiao, Yuzhi Xu, Danping Chen, Jun Chen, Yingjun Ma, Zong Dai, Xiaoyong Zou. (2017) Electrochemical assay for continuous monitoring of dynamic DNA methylation process. BIOSENSORS & BIOELECTRONICS, [PMID:28889069] [10.1016/j.bios.2017.08.013] |
| 18. Qing Wang, Pu Wang, Hong Zhou, Yan Hu, Chengshen Xie, Fei Gao, Ningjie Ma, Haoli Hou, Hao Zhang, Lijia Li. (2017) 5-Azacytidine specifically inhibits the NIH-3T3 PCD process induced by TNF-alpha and cycloheximide via affecting BCL-XL. JOURNAL OF CELLULAR BIOCHEMISTRY, 119 (2): (1501-1510). [PMID:28777484] [10.1002/jcb.26310] |
| 19. Jing Yin, Feilong Zhu, Weiyu Hao, Qi Xu, Jin Chang, Huili Wang, Baoyuan Guo. (2017) Acylamino acid chiral fungicides on toxiciepigenetics in lambda DNA methylation. FOOD AND CHEMICAL TOXICOLOGY, [PMID:28456568] [10.1016/j.fct.2017.04.038] |
| 20. Yongjun Sun, Chengyu Zhu, Wenquan Sun, Yanhua Xu, Xuefeng Xiao, Huaili Zheng, Huifang Wu, Cuiyun Liu. (2017) Plasma-initiated polymerization of chitosan-based CS-g-P(AM-DMDAAC) flocculant for the enhanced flocculation of low-algal-turbidity water. CARBOHYDRATE POLYMERS, [PMID:28325320] [10.1016/j.carbpol.2017.02.010] |
| 21. Lan Yang, Wenshuai Li, Kamiran Aihemaiti, Guangwei Jiang, Wenjia Gao, Hongyuan Li, Rongqin Huang. (2024) Dual-Drug nanoparticles activate pyroptosis in cancer cells synergistically target cancer stem cells to augment chemoimmunotherapy of triple-negative breast cancer. CHEMICAL ENGINEERING JOURNAL, [PMID:] [10.1016/j.cej.2024.158944] |
| 22. Guanyu Jin, Hao Liu, Zi Mei, Qionghua Jin, Sheng Ma, Lanqing Wang, Yuanzhen Su, Letian Lv, Zijuan Wang, Huicong Zhou, Mingqiang Li, Zehuan Huang, Xuesi Chen, Shixian Lv. (2024) Polymeric immunogel prevents tumor recurrence and metastasis by dual activation of innate and adaptive immunity. Bioactive Materials, [PMID:39618886] [10.1016/j.bioactmat.2024.11.008] |
| 23. Jingxin Li, Jing Huang, Xiaomin Tang, Shixin Zhang, Hailin Yang, Xiaoxia Bai, Huaili Zheng. (2025) Synthesis of visible light induced-flocculants via synergetic initiation of modified-titanium dioxide and potassium persulfate and their flocculation performances in the treatment of tetracycline. CHEMICAL ENGINEERING JOURNAL, [PMID:] [10.1016/j.cej.2025.160026] |
| 24. Yujie Wang, Jingxin Li, Honghua Wang, Shixin Zhang, Jie Zhang, Hailin Yang, Xiaomin Tang, Huaili Zheng. (2025) The improvement of flocculation performance of organic polymer flocculants via regulation of their branched structure and block structure in removal of soluble dyes from wastewater. Journal of Environmental Chemical Engineering, [PMID:] [10.1016/j.jece.2025.119960] |
| 25. Mengwan Jiang, Mingyue Chen, Wen Zou, Yingxin Xie, Jinjin Shi, Junjie Liu, Aibing Chen, Xiu Zhao. (2025) An immunostimulant nanomedicine enhances radioimmunotherapy by remodeling the tumor immunosuppressive landscape after radiotherapy. Acta Pharmaceutica Sinica B, [PMID:41685155] [10.1016/j.apsb.2025.11.012] |
| 26. Xiaofan Li, Guang Shi, Wanshu Guo, Kaishu Wen, Yifei Liu, Jiayue Cheng, Meichi Liu, Yuehui Yang, Xinyu Fan. (2025) Oxytocin may promote hippocampal neurogenesis in ischemic stroke rats via a pathway related to DNMT1-mediated Wnt3a/β-catenin. NEUROPHARMACOLOGY, [PMID:41314460] [10.1016/j.neuropharm.2025.110785] |
Our grade selection guide covers purity, stabilizer status, and application suitability for all variants in our catalog.
View Moligand™ grade guide →